LFCR ▲ +2.3% - Lifecore Biomedical, Inc. $LFCR - Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company Lifecore Biomedical signed an agreement to transfer its commercial site to support a global pharmaceutical company, a move that likely signals business expansion or strengthened partnership potential. The stock rose 2.3% on the news, reflecting investor optimism about the strategic transaction and its implications for the company's growth prospects. 02-SEP-2026 07:05 AM ET